[HTML][HTML] Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an …
Background Greater understanding of international cancer survival differences is needed.
We aimed to identify predictors and consequences of cancer diagnosis through emergency …
We aimed to identify predictors and consequences of cancer diagnosis through emergency …
[HTML][HTML] Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis …
Background COVID-19 pandemic responses impacted behaviour and health services. We
estimated the impact on incidence, stage and healthcare pathway to diagnosis for female …
estimated the impact on incidence, stage and healthcare pathway to diagnosis for female …
Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP …
M Eden, S Harrison, M Griffin, M Lambe… - Cancer …, 2019 - Elsevier
Background International cancer survival comparisons use cancer registration data to report
cancer survival, which informs the development of cancer policy and practice. Studies like …
cancer survival, which informs the development of cancer policy and practice. Studies like …
Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer
M Lüchtenborg, EJA Morris, D Tataru, VH Coupland… - Thorax, 2018 - thorax.bmj.com
Introduction The International Cancer Benchmarking Partnership (ICBP) identified significant
international differences in lung cancer survival. Differing levels of comorbid disease across …
international differences in lung cancer survival. Differing levels of comorbid disease across …
[HTML][HTML] Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking …
Background There is little evidence on variation in radiotherapy use in different countries,
although it is a key treatment modality for some patients with cancer. Here we aimed to …
although it is a key treatment modality for some patients with cancer. Here we aimed to …
[HTML][HTML] Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking …
Background There are few data on international variation in chemotherapy use, despite it
being a key treatment type for some patients with cancer. Here, we aimed to examine the …
being a key treatment type for some patients with cancer. Here, we aimed to examine the …
[HTML][HTML] Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project–international benchmarking of childhood cancer survival by …
A Lopez-Cortes, F Didonè, L Botta, LL Hjalgrim… - Frontiers in …, 2023 - frontiersin.org
Introduction Variation in stage at diagnosis of childhood cancers (CC) may explain
differences in survival rates observed across geographical regions. The BENCHISTA project …
differences in survival rates observed across geographical regions. The BENCHISTA project …
[CITATION][C] Impact of Societal Lockdown and Health System Response to the SARS-CoV-2 (COVID-19) Pandemic on Female Breast, Colorectal and Non-Small Cell …
G Greene, R Griffiths, A Akbari, J Han, M Jones… - 2021
[CITATION][C] A cancer health intelligence hub for Wales-positive outcomes from data linkage
J Warlow, C White, D Huws - EUROPEAN …, 2015 - … ST, HOBOKEN 07030-5774, NJ USA
[CITATION][C] Exploring the potential to link primary care data with the national cancer registry of the Welsh Cancer Intelligence and Surveillance Unit
C Johnson, J Warlow, C White… - EUROPEAN …, 2015 - … ST, HOBOKEN 07030-5774, NJ USA